drugset / Trial / NCT00394745
Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate potential effects of valsartan on lipid subfractions and other parameters in lipid metabolism in patients with essential hypertension and metabolic syndrome.
Timeline
- Start
- 2005-11
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valsartan | Small molecule | — | — |